Company Quick10K Filing
Prevail Therapeutics
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-26
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-05-24 Public Filing
8-K 2020-06-17
8-K 2020-05-14
8-K 2020-03-26
8-K 2020-03-02
8-K 2020-01-13
8-K 2020-01-09
8-K 2019-12-26
8-K 2019-11-15
8-K 2019-11-12
8-K 2019-10-08
8-K 2019-09-10
8-K 2019-08-15
8-K 2019-08-14
8-K 2019-06-24

Prevail Therapeutics Financials

PRVL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Avedro (AVDR) 462,164 75% -18.9 -33% 74,531 30,436 30,108 22,639 -24,846 -22,735 429,956
Milestone Pharmaceuticals (MIST) 460,181 -9.6 -26% 141,892 9,060 0 0 -36,941 -36,982 353,680
Kayne Anderson (KAAC) 457,974 393.6 0% 382,546 16,932 0 0 1,163 1,163 457,933
Aegean Marine Petroleum Network (ANW) 451,438 0% 1,600,933 1,011,342 0 0 0 0 929,119
ETFS Precious Metals Basket Trust (GLTR) 447,156 7.9 13% 442,710 216 0 0 56,636 56,636 447,156
Brigham Minerals (MNRL) 444,879 0% 15.0 1% 716,204 656,726 67,901 0 9,452 30,845 464,031
Perry Ellis (PERY) 436,499 38% 5.6 9% 554,666 169,797 880,665 332,305 49,882 74,302 415,161
New Fortress Energy LLC (NFE) 431,150 -3% -137.1 -2% 1,147,783 727,385 119,373 -3,851 -26,466 -5,783 793,018
IGM Biosciences (IGMS) 430,672 -23.3 -4% 269,856 15,234 0 0 -10,172 -10,172 236,993
Prevail Therapeutics (PRVL) 420,097 -6.7 -17% 203,429 21,401 0 0 -35,402 -35,402 236,932
Matlin & Partners (MPACU) 418,031 173.0 0% 329,723 12,132 0 0 1,263 2,415 417,877
Alfacourse (ALFA) 407,519 -40,331.9 -303% 5 19 0 0 -14 -10 407,514
ETFS Silver Trust (SIVR) 406,944 10.5 10% 394,201 97 0 0 38,813 38,813 406,944
Farmers Capital Bank (FFKT) 402,755 8.9 0% 10,900,000 1,434,070 0 0 15,694 34,787 309,509
Keryx Biopharmaceuticals (KERX) 402,246 0% -4.1 -60% 151,784 206,003 94,218 0 -90,838 -90,648 376,100
TCR2 Therapeutics (TCRR) 399,387 -10.2 -19% 179,511 8,357 0 0 -34,772 -34,214 349,653
Hennessy Capital Acquisition III (HCAC) 381,265 0% -35.1 -18% 421,802 475,144 431,588 0 -74,570 -21,261 746,662
Charter Financial (CHFN) 381,167 7.4 1% 1,625,835 1,401,429 0 0 16,852 35,949 265,269
Invesco DB Agriculture Fund (DBA) 380,908 -13.2 -7% 384,159 253 0 0 -28,794 -28,769 380,908
Karuna Therapeutics (KRTX) 379,989 -9.0 -15% 164,227 1,697 0 0 -24,178 -24,163 218,389

Balance Sheet ($'000)2019-06-302019-09-30
Cash202,186183,165
Accounts Receivable
Inventory
PP&E2,2732,785
Assets216,078203,429
Accounts Payable2,0034,952
Long-Term Debt
Liabilities15,03921,401
Stockholders' Equity201,039182,028
Income Statement ($'000)2019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D11,95516,836
SG&A3,7134,452
Tax
Net Income-15,103-20,299
Cash Flow ($'000)2019-06-302019-09-30
Cash Operating-18,501
Cash Investing-512
Cash Financing-8